Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&page=7
/vufind/Search/Results?lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&page=7
Search /vufind/Search2/Results?lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&page=7
PubPharm (853.717)
61
Study of the Efficacy and Safety of Olokizumab in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy : A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-a) Inhibitor Therapy - Clinical Rheumatoid Arthritis Development for Olokizumab (CREDO) 3
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
62
A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB(CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS : A LONG-TERM, OPEN-LABEL EXTENSION STUDY OF TOFACITINIB(CP-690,550) FOR THE TREATMENT OF PSORIATIC ARTHRITIS - OPAL Balance
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
63
A study to evaluate the efficacy and safety of mirabegron compared to solifenacin in patients with overactive bladder who are previously treated with another medicine but were not satisfied with that treatment. : A Double-Blind, Randomized, Parallel Group, Multi-Centre Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Subjects with Overactive Bladder (OAB) Treated with Antimuscarinics and Dissatisfied due to Lack of Efficacy - BEYOND Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
64
A Fabry Disease Gene Therapy Study : A Phase 1/2, Baseline-controlled, Non-randomised, Open-label, Single-ascending Dose Study of a Novel Adeno-associated Viral Vector (FLT190) in Patients With Fabry disease - MARVEL1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
65
A double-blinded, randomized, placebo-controlled phase I/IIa study in healthy subjects and patients with liver cirrhosis evaluating safety, pharmacokinetics and preliminary effect of single and multiple doses of GR3027. : Safety, tolerability and pharmacokinetics (PKs) of multiple oral doses of GR3027 in healthy male volunteers and single and multiple doses in patients with cirrhosis. Preliminary efficacy in cirrhotic patients with evidence of covert hepatic encephalopathy (CHE). A prospective, double-blinded, randomized, placebo-controlled phase I/IIa study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
66
A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of ABT 494 in Subjects with Crohn's Disease : A Phase 2, Multicenter, Open-Label Extension (OLE) Study to Observe the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of ABT-494 in Subjects with Crohn's Disease
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
67
A Phase III study of efficacy and safety of ligelizumab in the treatment of Chronic Spontaneous Urticaria in adolescents and adults inadequately controlled with H1-antihistamines : A multi-center, randomized, double-blind, active and placebo-controlled study to investigate the efficacy and safety of ligelizumab (QGE031) in the treatment of Chronic Spontaneous Urticaria (CSU) in adolescents and adults inadequately controlled with H1-antihistamines - Pearl 1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
68
Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia : Open-label, Single-arm Trial to Evaluate Antitumor Activity, Safety, and Pharmacokinetics of Isatuximab Used in Combination With Chemotherapy in PediatricPatients From 28 Days to Less Than 18 Years of Age With Relapsed/Refractory B or T Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia In First or Second Relapse - ISAKIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
69
Clinical study in Oral Lichen Planus (OLP) patients to assess how safe and effective the Rivelin®-CLO patches are when applied in the mouth : A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate when Administered Intra-orally Twice Daily in Patients with Oral Lichen Planus (OLP) using Rivelin®-CLO patches - Intra-oral treatment of OLP with Rivelin®-CLO patches
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
70
Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder : Randomised, double-blind, placebo-controlled trial evaluating the effects of naltrexone hydrochloride nasal spray on alcohol consumption in Alcohol Use Disorder - Effects of intranasal naltrexone on Alcohol Use Disorder
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
2
3
4
5
6
7
8
9
10
11
12
Nächster »
[85372]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
853.717
Aufsätze
853.716
E-Artikel
853.716
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
853.704
WHO International Clinical Trials Registry Plat...
3
Orphanet journal of rare diseases
2
ResearchSquare.com
1
Ayu
1
BioMed research international
1
Diabetology
1
Evidence-Based Complementary and Alternative Me...
1
Evidence-based complementary and alternative me...
1
Journal of cardiopulmonary rehabilitation and p...
1
Orphanet Journal of Rare Diseases
1
The National medical journal of India
Alle anzeigen ...
weniger ...
Thema
850.882
610
695.104
Study Type: Interventional
320.034
Recruitment Status: Not yet recruiting
182.938
Recruitment Status: Recruiting
182.310
Recruitment Status: Completed
125.472
Study Type: Observational
94.882
Phase: Phase 3
72.114
Phase: Phase 2
63.690
Recruitment Status: Complete: follow-up complete
60.420
Recruitment Status: Authorised-recruitment may ...
33.564
Phase: Phase 4
23.376
Phase: Phase 1
16.354
Phase: Phase 2/Phase 3
15.340
Phase: Other
12.074
Recruitment Status: Complete: follow-up continuing
9.066
Phase: New Treatment Measure Clinical Study
8.800
Phase: Phase 1/Phase 2
7.862
Phase: Retrospective study
7.002
Study Type: Diagnostic test
5.682
Study Type: Observational non invasive
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
572.398
2020-
281.318
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
832.733
Englisch
12.786
Unbestimmt
3.114
Spanisch
1.596
Niederländisch
1.504
Französisch
556
Deutsch
308
Dänisch
300
Finnisch
156
Italienisch
110
Schwedisch
56
Sanskrit
52
Galizisch
52
Portugiesisch
42
Latein
32
Norwegisch
30
Tschechisch
26
Afrikaans
26
Ungarisch
26
Slowakisch
18
Irisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...